Acetamide, N-[2-(5-chloro-2,6-dimethoxy-1H-benzimidazol-1-yl)ethyl]-;ACH-000143;Melatonin Receptor,HFD,toxicity,low,steatosis,Inhibitor,ACH-000143,inhibit,ACH 000143,obese,ACH000143;N-(2-(5-chloro-2,6-dimethoxy-1H-benzo[d]imidazol-1-yl)ethyl)acetamide;N-[2-(5-chloro-2,6-dimethoxy-1H-1,3-benzodiazol-1-yl)ethyl]acetamide;ACH-000143, 10 mM in DMSO;N-[2-(5-Chloro-2,6-dimethoxybenzimidazol-1-yl)ethyl]acetamide
ACH-000143 is a potent and orally active melatonin receptor agonist, with EC50 values of 0.06 nM and 0.32 nM for MT1 and MT2 receptors, respectively; used in the study of metabolic disorders such as obesity and hepatic steatosis.